What We Need to Consider During and After the SARS-CoV-2 Pandemic

Vector Borne Zoonotic Dis. 2020 Jul;20(7):477-483. doi: 10.1089/vbz.2020.2652. Epub 2020 May 29.


Even though extreme containment and mitigation strategies were implemented by numerous governments around the world to slow down the spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the number of critically ill patients and fatalities keeps rising. This crisis has highlighted the socioeconomic disparities of health care systems within and among countries. As new CoVID policies and responses are implemented to lessen the impact of the virus, it is imperative (1) to consider additional mitigation strategies critical for the development of effective countermeasures, (2) to promote long-term policies and strict regulations of the trade of wildlife and live animal markets, and (3) to advocate for necessary funding and investments in global health, specifically for the prevention of and response to natural and manmade pandemics. This document considers some of these challenges.

Keywords: CoVID-19; SARS-CoV-2; biodefense; pandemic.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Betacoronavirus*
  • Biological Evolution
  • COVID-19
  • COVID-19 Vaccines
  • Communicable Disease Control / organization & administration*
  • Coronavirus Infections / immunology
  • Coronavirus Infections / prevention & control*
  • Coronavirus Infections / virology*
  • Epidemiological Monitoring
  • Genome, Viral
  • Global Health*
  • Host Specificity
  • Humans
  • Pandemics / prevention & control*
  • Pneumonia, Viral / prevention & control*
  • Pneumonia, Viral / virology*
  • SARS-CoV-2
  • Viral Vaccines / immunology
  • Zoonoses


  • COVID-19 Vaccines
  • Viral Vaccines